Live Breaking News & Updates on Julip miller

Stay informed with the latest breaking news from Julip miller on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Julip miller and stay connected to the pulse of your community

Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated

Adaptimmune Therapeutics plc , a company redefining the treatment of solid tumor cancers with cell therapy, today announced that its strategic collaboration with Genentech entered in 2021, has been...

Philadelphia , Pennsylvania , United-states , Dana-lynch , Julip-miller , Adrian-rawcliffe , United-kindgom-newsfile-corp , Genentech , Corporate-communications , Exchange-commission , Nasdaq , Corporate-affairs

Adaptimmune Therapeutics PLC: Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated

Adaptimmune Therapeutics PLC: Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Pennsylvania , United-states , Philadelphia , Adrian-rawcliffe , Dana-lynch , Julip-miller , Dennis-riedl , Corporate-affairs , Adaptimmune-therapeutics , United-kindgom-newsfile-corp , Genentech , Corporate-communications

Results of Adaptimmune's SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet

Adaptimmune Therapeutics plc , a company redefining the treatment of solid tumor cancers with cell therapy, today announced that The Lancet published the company's pivotal Phase 2 data with afami-cel....

Philadelphia , Pennsylvania , United-states , Sandra-dangelo , Dana-lynch , Dennis-williams , Julip-miller , Corporate-affairs , Drug-administration , United-kindgom-newsfile-corp , Exchange-commission , Nasdaq

Adaptimmune Therapeutics PLC: Results of Adaptimmune's SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet

Adaptimmune Therapeutics PLC: Results of Adaptimmune's SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Pennsylvania , United-states , Philadelphia , Sandra-dangelo , Dennis-riedl , Dana-lynch , Dennis-williams , Julip-miller , Memorial-sloan-kettering-cancer-center , Corporate-communications , Stage-development , Nasdaq

Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise

Cintia Piccina returns as Chief Commercial Officer effective March 18, 2024 Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - February 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining the treatment of solid tumor cancers with cell therapy, today announced the reappointment of Cintia Piccina as Chief Commercial Officer effective March 18, 2024. Cintia served in this role from January 2022 to March 2023. Cintia will lead a rapidly expanding comme

Pennsylvania , United-states , Philadelphia , Brazil , Sao-paulo , Sãpaulo , Cintia-piccina , Dana-lynch , Julip-miller , Adrian-rawcliffe , Novartis , United-newsfile-corp

Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 | The Kingston Whig Standard

Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - February 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP),

Sao-paulo , Sãpaulo , Brazil , Philadelphia , Pennsylvania , United-states , United-kingdom , Dana-lynch , Cintia-piccina , Julip-miller , Adrian-rawcliffe , Exchange-commission

Adaptimmune to Report Q4 and Full Year 2023 Financial and Business Updates on Wednesday, March 6, 2024

Adaptimmune to Report Q4 and Full Year 2023 Financial and Business Updates on Wednesday, March 6, 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Pennsylvania , United-states , Philadelphia , Canada , Julip-miller , Dana-lynch , Corporate-affairs , Exchange-commission , United-newsfile-corp , Corporate-communications , Nasdaq , Private-securities-litigation-reform-act

Adaptimmune Announces U.S. FDA Acceptance of Biologics License Application for Afami-cel for the Treatment of Advanced Synovial Sarcoma with Priority Review

Adaptimmune Announces U.S. FDA Acceptance of Biologics License Application for Afami-cel for the Treatment of Advanced Synovial Sarcoma with Priority Review
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Pennsylvania , United-states , Philadelphia , Dennis-williams , Dana-lynch , Adrian-rawcliffe , Julip-miller , Corporate-affairs , Drug-administration , Stage-development , Exchange-commission , United-newsfile-corp

Adaptimmune Therapeutics PLC: Adaptimmune Announces U.S. FDA Acceptance of Biologics License Application for Afami-cel for the Treatment of Advanced Synovial Sarcoma with Priority Review

Adaptimmune Therapeutics PLC: Adaptimmune Announces U.S. FDA Acceptance of Biologics License Application for Afami-cel for the Treatment of Advanced Synovial Sarcoma with Priority Review
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Pennsylvania , United-states , Philadelphia , Stefan-klotter , Dennis-williams , Dana-lynch , Adrian-rawcliffe , Julip-miller , Corporate-affairs , Nasdaq , United-newsfile-corp , Exchange-commission

Adaptimmune Announces U.S. FDA Acceptance of Biologics License Application for Afami-cel for the Treatment of Advanced Synovial Sarcoma with Priority Review

Adaptimmune Therapeutics plc , a company redefining the treatment of solid tumor cancers with cell therapy, today announced that the U.S. Food and Drug Administration has accepted for priority review...

Pennsylvania , United-states , Philadelphia , Dana-lynch , Adrian-rawcliffe , Julip-miller , Dennis-williams , Drug-administration , Stage-development , Corporate-communications , Connective-tissue-oncology-society , Exchange-commission